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Abstract
Background: Rhinitis and asthma are very common diseases involving genetic and environmental
factors. Most patients with asthma also have rhinitis, which suggests the concept of 'one airway,
one disease.' A disintegrin and metalloproteinase 33 (ADAM33) is the first asthma-susceptible gene
to be discovered by positional cloning. To evaluate the potential influence of ADAM33 gene
polymorphisms on allergic rhinitis (AR) and allergic asthma (AS), a case-control study was
conducted on the Han population of northeast China.
Methods: Six polymorphic sites (V4, T+1, T2, T1, S1, and Q-1) were genotyped in 128 patients
with AR, 181 patients with AS, and 151 healthy controls (CTR). Genotypes were determined by
the polymerase chain restriction fragment length polymorphism (PCR-RFLP) method. Data were
analyzed using the chi-square test with Haploview software.
Results: The single nucleotide polymorphisms (SNPs), V4 G/C, T+1 A/G, and T1 G/A, of the
ADAM33 gene may be the causal variants in AR, whereas ADAM33 V4 G/C, T2 A/G, T1 G/A, and
Q-1A/G may participate in the susceptibility of AS.
Conclusion:  These results suggest that polymorphisms of the ADAM33 gene may modify
individual susceptibility to AR and AS in a Chinese Han population.
Background
Rhinitis is defined as inflammation of the nasal mucosa
and is characterised by nasal discharge, blockage, sneez-
ing, and itching [1,2]. Asthma is a chronic inflammatory
disorder of the airway which causes recurrent episodes of
wheezing, breathlessness, chest tightness, and coughing
in susceptible individuals. These episodes are usually
associated with widespread, but variable airflow obstruc-
tion that is often reversible, either spontaneously or with
treatment. The inflammation also causes an associated
increase in existing bronchial hyper-responsiveness
(BHR) to a variety of stimuli [1,2]. Epidemiologic studies
have consistently shown that asthma and rhinitis often
coexist in the same patients in every region of the world
[3-5], suggesting the concept of 'one airway, one disease.'
The basic premise is that rhinitis and asthma represent the
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manifestations of one syndrome in two parts of the respi-
ratory tract [6]. In order to raise awareness of the theory of
'one airway, one disease,' the Allergic Rhinitis and Its
Impact on Asthma (ARIA) Workshop Group publication
proposes three considerations for patients with allergic
respiratory disease [7].
ADAM33 is the first reported asthma-susceptible gene
identified by positional cloning [8]. ADAM33 is a com-
plex molecule, the expression of which is largely restricted
to mesenchymal cells, including fibroblasts and smooth
muscle cells, and codes for a protein important for cell
fusion, cell adhesion, cell signalling, and proteolysis [9].
The ADAM33 gene is located on chromosome 20p13 and
37 single nucleotide polymorphisms (SNPs) have initially
been identified [8]. Recently, several SNPs in the ADAM33
gene have been shown to be significantly associated with
asthma, BHR, and atopy [10]. Taken together, these find-
ings suggest an important role for ADAM33 in airway
remodelling and asthma [8]. To date, most data available
for ADAM33 and asthma have been obtained from Cau-
casians, but few data on ADAM33 SNPs associated with
asthma and atopic disease are available for Asian popula-
tions [11-14]. The aim of the present study was to deter-
mine whether ADAM33 SNPs are associated with allergic
rhinitis (AR) and allergic asthma (AS) in a Chinese Han
population.
Methods
Subjects
The study group consisted of 128 Chinese patients with
AR, 181 patients with AS, and 151 healthy controls (CTR).
They were recruited from The 2nd Clinical College of Har-
bin Medical University in China. The characteristics of the
study population are shown in Table 1. The diagnosis of
AR was made on the basis of the criteria of the Chinese
Society of Allergology (2003). Patients had to satisfy the
following AR criteria for inclusion: (1) nasal discharge,
blockage, and sneezing, with the 3 symptoms occurring
for more than 30 minutes on most days and for more than
6 months per year and (2) persistent symptoms for at least
1 year. AS was diagnosed according to the criteria of the
Chinese Society of Allergology (2003). Patients had to sat-
isfy the following AS criteria for inclusion: (1) continual
episodes of wheezing and dyspnea which require therapy,
(2) clinically-diagnosed wheezing, (3) reversible airway
obstruction shown by >15% variation in daily values of
volume in the 1st second of forced expiration (FEV1) and
peak expiratory flow (PEF) after inhalation or administra-
tion of a bronchodilator, and (4) elevated levels of serum
total IgE with at least one type of allergen-specific IgE.
One hundred fifty-one unrelated healthy Chinese Han
adults with no history of asthma and rhinitis were desig-
nated as CTR patients. Both patients and the healthy CTR
were recruited from the Heilongjiang Province of China
between August 2006 and June 2007. The present study
was approved by the Ethics Committee of the Harbin
Medical University and adhered to the tenets of the Hel-
sinki Declaration. Additionally, the written informed con-
sent was obtained from the patients.
DNA extraction and genotyping
Genomic DNA was extracted from 5 ml of frozen whole
blood using a DNA Extraction Kit (Qiagen, Germany),
according to the manufacturer's protocol and following
the manufacturers' instructions. We selected 6 SNPs in the
ADAM33 gene, which previously had been shown to have
an allelic and/or haplotype association with AS, including
V4(rs2787094), T+1(rs2280089), T2(rs2280090),
T1(rs2280091), S1(rs3918396), and Q-1(rs612709).
Using the unique rs accession numbers, SNP details and
sequence data are available through NCBI databases http:/
/www.ncbi.nlm.nih.gov. The polymorphic region was
amplified by PCR with a TGradient Thermoblock PCR
System (Iometra, Germany) in a 25 μl reaction solution
containing 0.3 μg genomic DNA, 1× PCR buffer, 0.3 mM
MgCl2, 0.2 mM dNTPs, 2 U TaqDNA polymerase (Takara,
Japan), and 0.1 μmol of each primer (Invitrogen, USA).
Genotyping primers and PCR programs are shown in
Table 2. PCR products were digested overnight with
restriction enzymes (NEB, UK), according to the manufac-
turer's protocol, and analyzed by 2% agarose gel electro-
phoresis. The restriction enzymes and the length of the
digested fragments are shown in Table 3.
Statistical analyses
We tested for the Hardy-Weinberg equilibrium (HWE)
among cases and controls separately. The genotype and
allele frequencies were obtained by direct counting. Statis-
tical significance was defined as a P < 0.05. In order to
obtain a measure of significance corrected for multiple
testing bias, we ran 10,000 permutations to compute P-
values using the Haploview program. Comparisons of the
distributions of the allele and genotype frequencies were
performed using the chi-square test. The relative risk asso-
ciated with rare alleles was estimated as an odds ratio
(OR) with a 95% confidence interval (CI).
Results
The genotype and allele frequencies of the ADAM33 gene
polymorphisms in patients and healthy controls are
Table 1: Description of study population
Characteristic AR AS CTR
Number of patients 128 181 151
Age (years) 39.27 ± 13.53 36.69 ± 11.53 37.18 ± 10.60
Gender (Female) 44(34.38%) 67(37.02%) 54(35.76%)
FEV1 (%) 100.95 ± 5.36 73.38 ± 10.66 102.84 ± 3.11BMC Medical Genetics 2008, 9:82 http://www.biomedcentral.com/1471-2350/9/82
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shown in Tables 4, 5 and 6. All of the six SNPs genotyped
were in HWE (P > 0.05) in the case and control cohorts.
The ADAM33 V4 G, T+1 A, and T1 G allele carrier frequen-
cies were significantly higher in AR patients than in the
CTR patients (P < 0.0001, = 0.0037, and < 0.0001, respec-
tively). Statistical analysis revealed no significant differ-
ences in the allele frequencies in T2 A/G, S1 G/A, and Q-1
A/G between AR and CTR patients. The differences at the
V4, T2, T1, and Q-1 sites between the AS and CTR groups
were significant (P < 0.0001). In contrast, no significant
differences in the allele frequency distribution at the T+1
and S1 sites between the AS and CTR groups were
observed. The ADAM33 V4 G, T2 A, T1 G, and Q-1 A allele
frequencies were significantly higher in the AS patients
than in the CTR patients (P < 0.0001). Correction for mul-
tiple tests was performed in this study.
Discussion
The work by van Eerdewegh et al. [8] that identified
ADAM33 as an asthma-susceptible gene using positional
cloning and an association study had a profound impact
on researchers investigating the genetics of bronchial
asthma. Polymorphisms of ADAM33 were originally
shown to be associated with BHR. In previous studies, T1,
T2, S2, and V-3 sites were reported in Japanese adult pop-
ulations [13,15], and these associations were also found
in our samples. In contrast, no association was found
between asthma and ADAM33 in Puerto Rican and Mexi-
can populations [16], and a Korean population [12]. The
study by van Eerdewegh [8] was the first to show that
ADAM33 polymorphisms (Q-1, S1, ST+4, ST+7, V-1, and
V4) and haplotypes were associated with asthma in Cau-
casian families. Recently, Raby et al. [17] performed a
family-based association study for childhood asthma and
ADAM33 SNPs in 652 nuclear families. They showed that
no single SNP was associated with childhood asthma in
Caucasians, but that a common haplotype of ADAM33
was associated with the disease. They also reported that T1
and T+1 were marginally associated with childhood
asthma in Hispanics. In previous association studies of
ADAM33 and asthma/asthma-associated phenotypes, no
single ADAM33 SNP was consistently associated with
asthma or intermediate phenotypes. This may be because
of allelic heterogeneity, a single disorder caused by differ-
ent mutations within a gene [14]. A number of studies
have been conducted to replicate the original findings,
some confirming and others refuting the association of
ADAM33 with asthma [17-19]. In the present study, adult
asthma was associated with ADAM33 SNPs, V4, T2, T1,
and Q-1, but not with the T+1 and S1, and the V4, T+1,
and T1 sites were also found to have significant associa-
tions with AR after correction for multiple tests. Compar-
ison of our results with those studies indicates that no
single SNP was universally associated with the asthma
phenotype. The genetic basis of asthma may differ
between different ethnic groups; it is possible that a par-
ticular subset of SNPs may be a risk factor for asthma in
Caucasians, and that a different subset may increase the
risk in Asian populations [13].
Epidemiological studies have clearly shown that rhinitis
and asthma are frequently concurrent [20,21]. The major-
Table 2: Primers and PCR programs for ADAM33 PCR-RFLP genotyping
Reference SNP ID Gene/SNP primer Sequence PCR program
rs2787094 ADAM33 V4C/G F 5'-ACACACAGAATGGGGGAGAG-3' 94°C 5 min; 35 cycles, 94°C 30 s,
ADAM33 V4C/G R 5'-CCAGAAGCAAAGGTCACACA-3' 53°C 30 s, 72°C 30 s; 72°C 5 min
rs2280089 ADAM33T+1A/G F 5'-CTGAGCCCAGAAACCTGATT-3' 94°C 5 min; 35 cycles, 94°C 30 s,
ADAM33T+1A/G R 5'-AGAAGGGAAGGGCTCATGC-3' 54°C 30 s, 72°C 30 s; 72°C 5 min
rs2280090 ADAM33 T2A/G F 5'-TTCTCAGGGTCTGGGAGAAA-3' 94°C 5 min; 35 cycles, 94°C 30 s,
ADAM33 T2A/G R 5'-GCCAACCTCCTGGACTCTTA-3' 52°C 30 s, 72°C 30 s; 72°C 5 min
rs2280091 ADAM33 T1A/G F 5'-ACTCAAGGTGACTGGGTGCT-3' 94°C 5 min; 35 cycles, 94°C 30 s,
ADAM33 T1A/G R 5'-GAGGGCATGAGGCTCACTTG-3' 54°C 30 s, 72°C 30 s; 72°C 5 min
rs3918396 ADAM33 S1A/G F 5'-TGTGCAGGCTGAAAGTATGC-3' 94°C 5 min; 35 cycles, 94°C 30 s,
ADAM33 S1A/G R 5'-AGAGCTCTGAGGAGGGGAAC-3' 50°C 30 s, 72°C 30 s; 72°C 5 min
rs612709 ADAM33 Q-1A/G F 5'-GGATTCAAACGGCAAGGAG-3' 94°C 5 min; 35 cycles, 94°C 30 s,
ADAM33 Q-1A/G R 5'-GTTCACCTAGATGGCCAGGA-3' 60°C 30 s, 72°C 30 s; 72°C 5 min
Table 3: Restriction enzymes and length of digested fragments
V4C/G T+1A/G T2A/G T1A/G S1A/G Q-1A/G
Enzyme PstI HpyAV HpyCH4III NcoI HinfI BtsCI
Length of digested G: 168+206 A: 284+28 A: 198+112 A: 140+260 G: 132+172 A: 20+138
fragments (bp) C: 374 G: 312 G: 310 G: 400 A: 304 G: 158BMC Medical Genetics 2008, 9:82 http://www.biomedcentral.com/1471-2350/9/82
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ity of patients with AS also have AR, which presents in
more than 75% of the patients with allergic asthma [22].
The relationship between AR and AS has become a focus
of research. Recent advances have demonstrated that sys-
temic inflammatory responses play a critical and integrat-
ing role in the pathophysiology of airway disease.
Substantial evidence has also shown that AR and AS are
closely linked, and the concept of 'one airway, one dis-
ease' has emerged [23]. Under this hypothesis, AS and AR
are regarded as a combined entity of upper and lower air-
way disease influenced by the inflammatory process. An
alteration of upper airway function could therefore affect
the function of the lower airway. Improvement of AR
symptoms is associated with resolution of AS symptoms.
On the other hand, deterioration of AR symptoms may
exacerbate AS symptoms. Consequently, appropriate
management of AR could decrease the risk of AS develop-
ing or AS exacerbation [23]. The results of several epide-
Table 4: Genotype frequency distribution and association study in ADAM33 between AR and CTR
Genotype Frequency, no.(%) x2 P value Odds ratio 
AR(n = 128) CTR(n = 151) (95% CI)
rs2787094 CC 46(35.94) 113(74.84) <0.0001 0.19(0.11–0.32)
CG 60(46.88) 32(21.19) <0.0001 3.28(1.95–5.53)
GG 22(17.18) 6(3.97) 0.0003 5.02(1.97–12.80)
rs2290089 AA 4(3.13) 0 0.0432
AG 51(39.84) 41(27.15) 0.0246 1.78(1.07–2.94)
GG 73(57.03) 110(72.85) 0.0056 0.49(0.30–0.82)
rs2280090 AA 0 0
AG 24(18.75) 12(7.95) 0.0073 2.67(1.28–5.59)
GG 104(81.25) 139(92.05) 0.0073 0.37(0.18–0.78)
rs2280091 AA 56(43.75) 117(77.48) <0.0001 0.23(0.13–0.38)
AG 55(42.97) 29(19.21) <0.0001 3.17(1.86–5.41)
GG 17(13.28) 5(3.31) 0.0021 4.47(1.60–12.49)
rs3918396 AA 100(78.12) 110(72.85) 0.3086
AG 28(21.88) 41(27.15) 0.3086
GG 0 0
rs612709 AA 0 0
AG 16(12.5) 11(7.28) 0.142
GG 112(87.5) 140(92.72) 0.142
Table 5: Genotype frequency distribution and association study in ADAM33 between AS and CTR
Genotype Frequency, no.(%) x2 P value Odds ratio 
AS(n = 181) CTR(n = 151) (95% CI)
rs2787094 CC 49(27.07) 113(74.84) <0.0001 0.12(0.08–0.20)
CG 78(43.09) 32(21.19) <0.0001 2.82(1.73–4.59)
GG 54(29.84) 6(3.97) <0.0001 10.28(4.28–24.69)
rs2290089 AA 0 0
AG 37(20.44) 41(27.15) 0.151
GG 144(79.56) 110(72.85) 0.151
rs2280090 AA 4(2.21) 0 0.1289
AG 49(27.07) 12(7.95) <0.0001 4.30(2.19–8.44)
GG 128(70.72) 139(92.05) <0.0001 0.21(0.11–0.41)
rs2280091 AA 63(34.81) 117(77.48) <0.0001 0.16(0.10–0.25)
AG 78(43.09) 29(19.21) <0.0001 3.19(1.93–5.26)
GG 40(22.10) 5(3.31) <0.0001 8.28(3.18–21.59)
rs3918396 AA 140(77.35) 110(72.85) 0.3437
AG 41(22.65) 41(27.15) 0.3437
GG 0 0
rs612709 AA 0 0
AG 44(24.31) 11(7.28) <0.0001 4.09(2.03–8.24)
GG 137(75.69) 140(92.72) <0.0001 0.24(0.12–0.49)BMC Medical Genetics 2008, 9:82 http://www.biomedcentral.com/1471-2350/9/82
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miologic surveys presented at the European Respiratory
Society Annual Congress (ERS) in 2007 supported the
concept of 'one airway, one disease' [24,25]. In this con-
text, we genotyped ADAM33 variants in AR cases and
healthy individuals to evaluate the potential influences of
ADAM33 gene polymorphisms on AR risk, and to deter-
mine whether ADAM33 is also the susceptible gene for
AR. As expected, some significant associations were
observed in AR patients. Although there are some differ-
ences between AR and AS in the statistical analysis results
with respect to ADAM33 genetic susceptibility, polymor-
phisms of the ADAM33 gene may modify individual sus-
ceptibility to AR and AS in a Chinese Han population.
Conclusion
Our data suggest that the ADAM33 gene may be involved
in the susceptibility to AR and AS in a Chinese Han popu-
lation. The SNPs (V4 G/C, T+1 A/G, and T1 G/A) of the
ADAM33 gene may play an important role in the suscep-
tibility of AR disease, whereas ADAM33 V4 G/C, T2 A/G,
T1 G/A, and Q-1A/G may participate in the susceptibility
to AS. Considering that the limited sample size may pro-
duce relative risk estimates lacking adequate precision,
extended analyses with a larger sample size should be car-
ried out from different ethnic origins to further verify this
association.
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